Bacterial efflux pump NorC (NorC)

NorC is a chromosomally encoded major facilitator superfamily (MFS) transporter in *Staphylococcus aureus* and other pathogens[5]. It comprises 12 transmembrane segments and is implicated in exporting various substrates—including fluoroquinolone antibiotics and biocides—out of bacterial cells, contributing to multidrug resistance phenotypes[5][4][1]. NorC is under negative regulatory control by the MgrA protein; its overexpression increases resistance to several quinolones in *S. aureus*[4]. Structural studies reveal that NorC can be inhibited by single-domain antibodies that physically block substrate entry[3], providing a mechanism for therapeutic targeting. Efflux pump blockade is an attractive strategy to reverse resistance, but clinical translation of effective inhibitors remains a challenge due to toxicity and pharmacological limitations[2][3]. NorC also contributes to biofilm formation and overall bacterial defense against host and environmental antimicrobials[1].

Other names

NorC efflux pumpMFS NorCStaphylococcus aureus NorC

Drugs targeting NorC generally act as efflux pump inhibitors, blocking the transporter's ability to extrude drugs and thereby increasing intracellular antibiotic concentration—antibiotic adjuvant strategy. Antibodies can stabilize NorC in an inactive (outward-open) state, physically blocking substrate access.